Call us at 630-617-2000

Help us by participating in
our research studies

Irritable Bowel Syndrome With Diarrhea

A 12-week double-blind, randomised, placebo-controlled, parallel-group phase III study, followed by a 4-week randomised withdrawal period to evaluate the efficacy and safety of oral ibodutant 10 mg once daily in female patients with irritable bowel syndrome with diarrhea (IBS-D)